Immunicum AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.09.22	Mendus AB: Mendus to participate in upcoming conferences in September (GlobeNewswire)
26.08.22	Mendus AB: Mendus AB (publ) interim report April – June 2022 (GlobeNewswire)
26.08.22	Mendus AB: Mendus announces financing commitments totaling up to SEK 250 million with Van Herk Investments and Negma Group (GlobeNewswire)
14.07.22	Mendus AB: Mendus Publishes Preclinical Data Demonstrating Significant Anti-Tumor Synergies of Intratumoral Immune Priming with CTLA-4 Inhibition (GlobeNewswire)
23.06.22	Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB (GlobeNewswire)
09.06.22	Immunicum AB: Immunicum Received FDA Orphan Drug Designation for Ilixadencel as Treatment of Gastrointestinal Stromal Tumors (GIST) (GlobeNewswire)
01.06.22	Immunicum AB: Immunicum to Participate in Upcoming Conferences (GlobeNewswire)
16.05.22	Immunicum AB: Immunicum Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment (GlobeNewswire)
10.05.22	Immunicum AB: Report from the Annual General Meeting of Immunicum AB (publ) on 10 May 2022 (GlobeNewswire)
10.05.22	Immunicum AB: Immunicum AB (publ) Interim Report January – March 2022 (GlobeNewswire)
05.05.22	Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer (GlobeNewswire)
03.05.22	Immunicum AB: Immunicum to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Myeloid Leukemia (GlobeNewswire)
28.04.22	Immunicum AB: Immunicum Publishes Phase II MERECA Trial Results of Ilixadencel in Kidney Cancer in European Urology Open Sciences (GlobeNewswire)
19.04.22	Immunicum AB: Immunicum to Participate in Upcoming Conferences (GlobeNewswire)
15.04.22	Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021 (GlobeNewswire)
14.04.22	Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT (GlobeNewswire)
08.04.22	Immunicum AB: Notice of Annual General Meeting in Immunicum AB (publ) (GlobeNewswire)
07.03.22	Immunicum AB: Invitation to Immunicum's Investor Event in Gothenburg on March 14, 2022 (GlobeNewswire)
17.02.22	Immunicum AB: Immunicum AB (publ) Announces Q4 and Year-End Results 2021 (GlobeNewswire)
10.02.22	Immunicum AB: Invitation to Immunicum's Full-Year 2021 Review and Pipeline and Strategy Outlook Held as a Hybrid Event on February 17, 2022 (GlobeNewswire)
05.01.22	Immunicum Transfers Patent Rights for Modified Adenovirus to Elicera Therapeutics (GlobeNewswire)
03.01.22	Immunicum to Participate in Upcoming Investor and Industry Conferences in January (GlobeNewswire)
21.12.21	Immunicum Publishes Year-End Letter by CEO and Announces Upcoming Shareholder Event to Present Pipeline Outlook (GlobeNewswire)
11.12.21	Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001 Treatment in AML Patients at ASH 2021 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Immunicum AB

Aktien Top/Flop

Meistgelesene Nachrichten